Ambicare Health out of Fife, Scotland just received the European CE mark of approval and is subsequently launching the Ambulight PDT device for on-the-go photodynamic therapy. PDT typically requires in-hospital equipment, so skin cancer patients are tied to a clinical environment when receiving treatment. The Ambulight PDT is small and portable enough to be worn inconspicuously as a skin patch, taking the patient out of the hospital for a better experience and reduced costs.
Features from the product page:
A single use device, packaged as a disposable dressing, it is simple to set up with the patient Wearable low powered light source technology allows greater freedom of movement during treatment Low light intensity – which has the potential to reduce pain A high uniformity of light, wavelength matched to the PDT cream and treatment protocol Convenient for patient, medical professional and healthcare provider
Here’s a BBC report about the device:
Press release: Ambicare Health demonstrates it’s [sic] revolutionary device to key European practitioners in Monaco…
Product page: Ambulight PDT …
